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ABSTRACT: The search for a pharmacologic treatment of cocaine addiction has lead to
the study of possible cocaine analogs to be used as substitution therapy, much like
methadone is used in heroin addiction. The goal is to identify compounds which may
produce cross-tolerance to cocaine and thus blunt cocaine’s euphoric effects. The effects of
acute (three hours) and chronic (seven days) exposure to intravenous cocaine, cocaethylene,
or isopropyl cocaine on the response to a subsequent cocaine challenge were examined.
Neurochemical (microdialysis
behavioral (locomotor activity)

nucleus accumbens dopamine level
measures were compared.

measurements) and

The relative

potency of

isopropyl cocaine compared to cocaine in the anesthetized rat was also examined. The
results of the acute tolerance experiments showed no behavioral tolerance in any group;
however, there was a decrease in dopamine response to a cocaine challenge in the cocaineand cocaethylene-pretreated groups. Though acute neurochemical tolerance was suggested,
these data need to be interpreted with caution as the cocaine pretreatment group had a
sustained, high baseline during the three hour maintenance which may be the animals’
maximal response to cocaine. Cocaethylene seemed to produce acute tolerance to itself
during the three hour maintenance phase as neither the neurochemical nor the behavioral
effects

were

sustained.

Chronically,

cocaine-

and

cocaethylene-pretreated

animals

demonstrated a reduced response to a subsequent cocaine challenge compared to placebo;
the isopropyl cocaine pretreated animals behaved no differently from the placebo group.
Isopropyl cocaine is much less potent than cocaine in its ability to elevate dopamine in
both awake and anesthetized animals. Most significantly, these studies show that behavioral
tolerance was achieved after one week of cocaethylene pretreatment. Cocaethylene or its
related analogs shows some promise as a possible pharmacological treatment of cocaine
addiction as chronic treatment blunts the subsequent effects of cocaine.
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1. INTRODUCTION
The 1985 National Household Survey on Drug Abuse estimated the number of
individuals over the age of 12 that have tried cocaine to be approximately 25 million in
the United States (1988). This increasing problem has lead

to continued interest in

research in both cocaine and its analogs, both to understand the nature and effects of cocaine
and also to search for possible pharmacological modalities to treat cocaine dependence
(Leshner, 1996; Seifert/., 1996).
Currently

there are

no effective

treatments

for

cocaine

addiction.

Studies

evaluating the treatment ol this illness with nonpharmacological methods such as talk
therapy or acupuncture have yielded poor results so lar. While effective medications have
yet to be identified, the approaches for finding a pharmacological treatment for cocaine
addiction

have been many: some researchers search for an agent that would treat the

addiction by acting as a cocaine antagonist much like naloxone acts in opioid overdoses,
others explore the use ot antidepressants to decrease craving and subsequent drug-seeking
behavior as with buproprion for treatment of nicotine addiction. In this thesis, compounds
which can induce cross-tolerance to subsequent cocaine use are examined to see il these
cocaine analogs have potential for therapy. If tolerance to cocaine can be successfully shown
to occur with chronically administered cocaethylene or isopropyl cocaine, then there may
be a potential benefit if these or other cocaine analog can be used to treat cocaine abusers
much in the same way that methadone is used currently to maintain heroin addicts.
It

is

presently

believed

that

cocaine

and

other

psychoactive

drugs

cause

reinforcement in animals and presumably euphoria in humans through the elevation of
dopamine levels in the nucleus accumbens; cocaine is also known to elevate extracellular
concentrations of other monoamine neurotransmitters (Bradberry et al., 1993; Koob and
Bloom,

1988;

Ritz

et

al,

1987).

The

increases

in

extracellular

neurotransmitter

concentrations are believed to be due to cocaine’s binding to monoamine transporters
thereby preventing dopamine, norepinephrine, and serotonin reuptake after initial release
(Hammer and Cooke, 1994).
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Drug tolerance is defined as an attenuation of drug responsiveness resulting from
prior exposure to the drug (Pan et al., 1991). By producing tolerance in an experimental
subject, a constant amount ol cocaine will produce a reduced euphoric effect. Numerous
studies have demonstrated tolerance in the rat model with chronic cocaine administration
(Emmett-Oglesby et al., 1993; Frank et al., 1992; Katz et al., 1992; Masserano et al,
1994).
Between 70% and 80% of cocaine abusers concurrently use ethanol (Grant and
Harford, 1990). Cocaethylene is a cocaine analog and metabolite formed in vivo following
concurrent cocaine and ethanol consumption as a result of enzymatic transesterification
(Bailey,

1993; Boyer and Petersen, 1992; Dean et al., 1991; Jatlow et al., 1991). It is

pharmacologically active and produces a euphoric effect in humans that is similar
cocaine but is eliminated

more slowly (Bradberry et al.,

1993; Hearn et al.,

to

1991;

McCance et al., 1995; McCance-Katz et al., 1993). Cocaethylene binds equipotently to
cocaine at dopamine

transporters but exhibits a lower

binding alfinity

to serotonin

transporters than cocaine (Elsworth et al, 1993; Hearn et al., 1991). Isopropyl cocaine is an
analog of cocaine with an isopropyl moiety substituted for the methyl group. Many ol the
properties of isopropyl cocaine are currently under study. This analog is even more
selective for the dopamine transporter than cocaethylene (Elsworth et al., 1993; Jatlow,
1993). Differences in monoamine transporter selectivity may alter the neurotransmitter
pattern of neurochemical tolerance resulting from effects of cocaine analogs, thus altering
the subjective effects of subsequent cocaine. The structures of cocaine, cocaethylene, and
isopropyl cocaine are presented in Figure 1.
Three groups of experiments have been conducted in this study. Acute tolerance was
examined in the first experiment. The effects of an intravenous bolus and constant infusion
of cocaine or cocaine analog on a rat that is free to move about a cage followed by a
cocaine challenge were examined. Extracellular dopamine levels in the nucleus accumbens
were measured using the technique of microdialysis. These data were collected along with
photocell measurements of rat locomotor activity. Second, the dopamine response in the
nucleus accumbens of an anesthetized rat to challenges of cocaine or cocaine analog were
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at

increasing extracellular

dopamine. Finally, the effects of a continuous seven day constant infusion of cocaine,
cocaethylene, and isopropyl cocaine on the behavioral activation

in animals given a

subsequent challenge of cocaine were determined. This experiment addressed the issue of
behavioral response to a cocaine challenge after a chronic pretreatment with an analog.
The hypothesis to be tested was that continuous infusion of cocaine, cocaethylene, or
isopropyl cocaine would blunt response to later cocaine challenge. Two different lengths of
time for the maintenance phase were examined: one study included a three hour constant
infusion phase while the other a week long

period

of pre-treatment.

Also,

further

characterization of cocaine, cocaethylene, and isopropyl cocaine was performed.
All

experiments and procedures

(including

the construction and

stereotactic

insertion of the microdialysis probes) for this thesis were performed by me except for the
post-mortem plasma drug analysis using extraction and HPLC which was performed in Dr.
Jatlow’s laboratory and the tail vein injections during the anesthetized rat studies which
were performed by Dr. Charles Bradberry.

2. MATERIALS AND METHODS
2.1 Introduction for Acute Tolerance Studies
Male Sprague-Dawley rats (obtained from CAMM) weighing between 250-M50
grams were used in these studies. Food and water were provided ad libitum at all times.
All animal use procedures were in strict accordance with the NIH Guide for the Care and
Use of Laboratory Animals (1985) and were approved

by the local

Animal

Studies

Committee. For the Acute Tolerance Studies, the animals were anesthetized during which
time both a microdialysis guide cannula and a jugular catheter were implanted. The rat
was allowed to recover for at least two full days but not longer than one week prior to
studies. Preparation for an experiment included stereotactic insertion of the microdialysis
probe in the nucleus accumbens through the guide cannula and connecting the animal to a
liquid swivel in the cages; this procedure required minimal halothane administration. The
rats were allowed to recover overnight during which behavioral data were collected. The
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next day, extracellular dopamine concentrations in the nucleus accumbens were measured
with in vivo microdialysis prior to, during, and subsequent to drug challenge at 20 minute
intervals, and the number of non-consecutive breaks of infrared photo beams using an
infrared detector was recorded at five minute intervals tor behavioral measurements; both
were continued for the entire experiment. After a baseline of two hours, a bolus followed
by a constant infusion of drug was administered through the jugular catheter. This first
bolus and infusion of drug was cocaine, cocaethylene, or isopropyl cocaine respectively.
Three hours later, a challenge of cocaine was given by bolus and dialysis samples were
collected for another hour with no more drug administered. At the end of the hour the
animal was sacrificed following equithesin anesthesia. Blood was collected, centrifuged,
and

the plasma

was

later

analyzed.

Probe

placement

was

verified

by

analyzing

postmortem, formaldehyde-fixed brains stained with cresyl violet and sliced in 100 fim
sections.

22 Surgery for Acute Tolerance Studies
Rats were placed in an induction box and given 5% halothane mixed with 80%
oxygen. Upon induction, it was immediately

removed

and given an intraperitoneal

injection of equithesin (0.35 mL/100 gm) (see Table 1: Equithesin). The equithesin was
allowed at least five minutes to take effect before the surgery began. Additional anesthetic
was given as needed throughout the procedure to insure surgical anesthesia. Attention was
paid to sterile technique. Rat body temperature was maintained with an electric heating
pad set at 37° C.

Table l: Equithesin
nembutal (50 mg/mL pentobarbital)

16.20

mL

4.25

gm

propane-1,2-diol (propylene glycol)

39.60

mL

absolute ethanol

10.00

mL

chloral hydrate

add to volume of 100 mL with H2O

Tobias T. Lee
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The fur above the skull and in the upper portions of the thorax was shaved; care was
taken not to damage the whiskers so as not to affect behavior. An incision approximately
1.5-2 cm in length was made along the right midclavicular line above the point where
pulsation was found in the supine animal. Careful dissection yielded the jugular vein which
was exposed. The vein was tied off with 2-0 silk surgical thread. The animal was then
turned over, and an incision approximately 2 cm long was made midsagitally

along the

top of the skull. Using scissors, a subcutaneous path was made from the caudal aspect of the
incision at the head to the exposed jugular vein. The jugular catheter was then passed
through the subcutaneous path. A small nick was made in the jugular vein proximal to the
occlusion and the jugular catheter was inserted to the right atrium of the heart.
The jugular catheter was made with 13 cm of silastic medical grade tubing (Dow
Corning, 0.020 inch i.d., 0.037 inch o.d.). At the end to be inserted into the jugular vein,
two small beads of 6382 RTV Silicone Elastomer (Factor II, AZ) were placed 3.5 cm from
the end to hold the catheter in position in vivo. The other end consisted of a piece of 23
gauge tubing bent to form an L shape attached to the silastic

tubing by multipurpose

sealant (Dow Corning 732 RTV). Before surgery, heparinized saline was run into the jugular
catheter to prevent air emboli.
Once inserted to the beads, the jugular catheter was tied

in place with more

surgical thread. Proper placement was checked by syringe aspiration. A small amount of
heparinized saline was then injected into the rat to clear the jugular cannula of blood and
ensure patency. The rat was then placed in a stereotaxic frame after the thoracic wound was
closed.
After the rat was placed in the stereotaxic frame in the flat skull position, the skull
was exposed from the previous incision by spreading the layers of the scalp using cotton
swabs. An 18 gauge stainless-steel guide cannula of 8 mm length was implanted 1.0 mm
below the skull surface over the nucleus accumbens using the coordinates AP +1.7 mm, L 1.5 mm, and V -8.3 mm from bregma (Paxinos and Watson, 1982). Two stainless-steel
screws were placed "in the skull to secure the dental acrylic which anchored in place the
microdialysis guide cannula, the jugular catheter L piece, and the slotted screw used by the

Tobias T. Lee
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liquid swivel for awake animal experiments. The rats were then returned to their cages to
recover from one to six days with free access to water and food before being placed in the
experimental set-up.

23 Microdialysis
Concentric-style microdialysis probes (Bradberry et al., 1993; Bradberry and
Roth, 1989; Johnson and Justice, 1983) were used. A hollow dialysis fiber (300 /^m i.d.,
330 gm o.d.) with one end epoxy-sealed and containing a fused silica fiber (102 /dm i.d.,
163 /dm o.d.) was housed in a 23 gauge (0.64 mm o.d.), thin-walled hypodermic tube. The
outlet opening was through another piece of fused silica placed into the hypodermic tube.
Epoxy was applied as sealant at the end of the dialysis fiber and spread generously along
both open ends of the hypodermic tube to provide a water-tight seal around the fused
silica. This forced the perfusion buffer to travel in a path from the inlet opening along the
dialysis membrane and out the outlet openings.
The standard probe was housed in a cut 100 fiL pipette tip (not shown in Figure 2:
Microdialysis Probe) filled with epoxy to prevent damage to the probe body both during
placement and also during the experiments for the Acute Tolerance studies. The rat was
allowed to run freely in a standard cage. The pipette tip, fixed at a measured distance
from the microdialysis tip, also provided a guide as to how far the probe needed to be
inserted in the experimental animal: full insertion of the probe in the guide cannula (placed
during surgery) to the pipette tip determined the precise dorsal-ventral distance of 7 mm
below the skull. The length of the exposed dialysis membrane in the probe was 2 mm
which allowed collection of dopamine along the entire dorsal-ventral aspect of the nucleus
accumbens.
The microdialysis probe was inserted into the study animal under anesthesia (2%
halothane and 80% oxygen) one day prior to the experiment. Then the animal was attached
to the liquid swivel and placed in the experimental cage. Probes were perfused overnight
with artificial cerebral spinal fluid (ACSF), containing in mM: KC1 2.4, NaCL 137, CaCl2
1.2, MgCl2 1.2, NaH2P04 0.9, and ascorbic acid 0.08, at pH 7.4 at a flow rate of
1 /rL/min by infusion pump. On the day of the experiment the flow rate was increased to

Tobias T. Lee
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2 pL/min for at least half an hour prior to collection of the first sample. Samples were
collected

through fused silica

lines by a fraction collector every 20 minutes for the

duration of the experiment and were analyzed using HPLC.

2.4 Behavioral Studies for Acute Tolerance Studies
Rat behavioral data were collected in the standard experimental cages which were
modified by the addition of four infrared detectors spaced evenly along the length 1.75
inches from the cage floor. The Med-PC program (MED Associates & Thomas A. Tatham
version 2) running on an IBM compatible computer recorded the number of non-consecutive
beam breaks a rat made at five minute intervals until the conclusion ol the experiment. On
the night previous to the experiment day (after microdialysis probe insertion) behavioral
data were recorded for the rats placed

in the cages

to assess any circadian

rhythm

variations.

2.5 Schedule and Drug Administration for Acute Tolerance Studies
On the morning ol the study day, the ACSF was increased from the overnight flow
rate ol 1 /tL/min to 2 pL/min lor at least half an hour prior to collection ol the first
microdialysis baseline sample. Collection ol baseline behavioral information and baseline
dopamine concentration levels at the nucleus accumbens was begun at the same time and
continued lor two hours prior to the first bolus of study drug. As previously mentioned,
behavioral data were collected at five minute intervals, and microdialysis samples were
collected at 20 minute intervals.
After a two hour baseline period, the first bolus ol 3 /tmol/kg of study drug—
cocaine, cocaethylene, or isopropyl cocaine—was infused into the jugular catheter over 30
seconds. This was immediately lollowed by a maintenance flow rate of the bolused drug
at 17 fiL/min of the same 3 /zmol/mL solution. The maintenance rate was calculated to
achieve an approximate blood plasma concentration goal of 200 ng/mL and was based on a
reported clearance rate of 73.5 ±9.5 mL/min and 82.8 ± 7.4 mL/min for intravenous
cocaine and cocaethylene respectively (Nobiletti et al., 1994). These clearance rates were
not significantly different. Clearance was estimated as 80 ml/min for both compounds.
200 ng/ml x 80 ml/min = 16 /ig/min infusion rate. Isopropyl cocaine clearance rates were
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estimated to be similar though currently no studies have yet been done to quantity the
pharmacokinetic properties ot this compound.

Table 2: Study Drugs
salt MW

active component MW

infusion rate

cocaine • HC1

339.9

303.4

17.3 /ig/min (51 nmol/min)

cocaethylene • fumarate

491.5

317.4

25.1 /ig/min (51 nmol/min)

isopropyl cocaine • HC1

368.0

331.5

18.7 /ig/min (51 nmol/min)

dm?

MW: molecular weight

Three hours after the initial bolus, the constant infusion of drug was stopped and a
challenge of 3 ^mol/kg cocaine in a 3 fdmol/mL solution was given intravenously with
microdialysis
immediately

and

behavioral

data

continuing

for

one

hour.

The

rats

were

then

anesthetized with 0.12 mL/100 gm equithesin intravenously through the

jugular catheter and transported in a closed

box with halothane to be sacrificed.

The

plasma was collected in a vacutainer containing potassium oxalate and sodium fluoride,
vortexed for 10 seconds, and centrifuged for three minutes. The plasma was then removed
and frozen for later extraction and analysis. The brains were removed and placed in
formalin; later, 100 //m coronal sections were made by vibratome and stained with cresyl
violet to verify probe placement. Drug concentrations in the rat during the experiment were
verified by plasma analysis using extraction, and HPLC was performed in Dr. Jatlow’s
laboratory using a method previously described (Jatlow and Nadim, 1990).

2JS Chromatography
Determination

of dialysate

dopamine

content

was

performed

using

liquid

chromatography with microbore columns packed in the laboratory with 3 fdm Spherisorb
ODS2 particles and electrochemical

detection

(Eapp: +0.6 V vs Ag/AgCl

reference,

Bioanalytical System, West Lafayette, IN). The output was to a strip chart recorder.
Mobile

phase

consisted

of

9

mg/L

sodium

monophosphate,

320

mg/L

sodium

octanesulfonate, 120 mg/L methanol, 0.1 mM disodium EDTA, and 300 fdL triethylamine.

Page 9
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The pH was adjusted with sodium hydroxide or phosphoric acid until its value was 5.
Mobile phase was pumped using an ESA 580 pump at a flow rate of 0.200 mL/min and
samples were injected by ESA 465 autosampler.

2.7 Isopropyl Cocaine Dosing Studies in the Anesthetized Rat
Dopamine response studies comparing various dosages of isopropyl
cocaine were conducted with chloral hydrate anesthetized

cocaine to

rats using a microdialysis

procedure previously described (Bradberry et al., 1993). An intraperitoneal injection of
400 mg/kg chloral hydrate was given to the rat; additional chloral hydrate supplement was
provided

as needed

to maintain surgical

anesthesia

for

the entire

experiment. After chloral hydrate administration, the rat was placed

duration

of the

in the flat skull

position, and the skull was exposed as described in section 2.2, Surgery for Acute Tolerance
Studies. No guide cannula was placed as in the awake animal experiments; rather, a
standard probe was lowered slowly to the nucleus accumbens—AP +1.7 mm, L -1.5 mm,
and V -8.3 mm Irom bregma. The probe position was secured with methacrylate adhesive.
The rat was then removed from the stereotaxic frame for the experiment. Rat body
temperature was maintained with an electric heating pad set at 37° C. The perfusion buffer
for microdialysis

was

identical

to

that used

in

the experiment

described

(section 2.3, Microdialysis) and flowed at 2 /tL/min. Samples were collected

earlier

every 20

minutes. A stable baseline dopamine level was confirmed by a two hour collection period
before drug infusion. After the baseline period, cocaine at 3 /imol/kg; isopropyl cocaine at
6, 12, or 24 //mol/kg; or both cocaine at 3 /tmol/kg and isopropyl cocaine at 12 /rmol/kg
was infused in the rat by tail vein injection over 30 seconds. Dopamine concentrations in
the dialysate

were

measured

for

another two

hours

as

described

in

section

2.6,

Chromatography.

2& Chronic Tolerance Studies
These rats were prepared with a jugular catheter as described in section 2.2, Surgery
for Acute Tolerance Studies. In addition, an Alzet 2ML1 osmotic pump was implanted
subcutaneously on the back, midline and slightly posterior to the scapulae. The 2ML1
pump solution was released at a rate of

10.0 pL per hour for seven days which delivered

Page 10
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drug into the free jugular vein via silastic medical grade tubing. Thus bilateral jugular
veins were catheterized; venous blood flow occurred through collaterals. Care was paid to
correct filling, incubation, and sterile handling of the pump as prescribed by Alzet. A free
loop of silastic tubing was left exposed at the back of the neck after pump implantation to
allow ligation and termination of continuous fluid infusion during the experiment. The
minipump was filled with sterile water (control), cocaine solution, cocaethylene solution,
or isopropyl cocaine solution in amounts given in the following Table 3: Minipump Study
Drugs. Desired plasma levels were 85 to 90 ng/ml for the cocaine and cocaethylene
animals. As can be seen, isopropyl cocaine was infused at one half the rate of the other two
test drugs because of limited availability of this specially synthesized compound. The
experimental design did not permit verification of plasma levels.

Table 3: Minipump Study Drugs
salt MW

active component MW

infusion rate

cocaine • HC1

339.9

303.4

7.7 /rg/min (22.6 nmol/min)

cocaethylene • fumarate

491.5

317.4

11.1 pglmin (22.6 nmol/min)

isopropyl cocaine • HC1

368.0

331.5

4.6/Jg/min (11.3 nmol/min)

dru?

MW: molecular weight

1.68 mL total delivered by pump for week at 10 pL per hour

No microdialysis was conducted on these animals. Behavioral data were collected
overnight on the sixth day after implantation of mini-pump. The next morning an hour of
baseline behavior was collected

after which the continuous infusion by minipump was

stopped by ligation of tubing running to the jugular catheter. A washout period of two
hours to clear plasma of the chronically infused drug was followed

by a bolus of 3

/rmol/kg cocaine via jugular catheter and one more hour of behavioral data collection. The
rats were then sacrificed with an overdose of equithesin or chloral hydrate.
During the week of constant infusion, the jugular catheter connecting to the outside
by way of the L pwece and dental acrylic was flushed daily with heparinized saline to
maintain patency. Animals that appeared to be in distress after the surgery were sacrificed
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before the scheduled experiment date. Rats were housed individually and given free access
to food and water.

2.9 Data Analysis
Dopamine levels were calculated as femtomoles per microliter

lor statistical

analysis (uncorrected for probe recovery). One way repeated measures analysis of variance
(ANOVA) was used to determine if administration of drug produced a significant change in
dopamine levels or behavioral response within a group receiving a particular treatment.
Two way repeated measures ANOVA was used to determine if there was a significant
difference between experimental groups. An unpaired, two-tailed,

Student’s t-test was

used to compare activity after cocaine challenge between groups. The level of statistical
significance was set at p < 0.05. All

graphs represent dopamine data as a percentage ot

baseline. The mean of the three points prior to drug administration was used to determine
the pre-drug baseline.

3. RESULTS
3.1 Results

from Acute Tolerance Studies

Some animals were sacrificed

before drug challenge at the end of continuous

cocaine infusion in order to measure plasma drug levels. Mean plasma cocaine levels were
481 ±66 ng/mL cocaine {n = 9) which were different from initially calculated. The target
plasma drug concentration was 200 ng/mL which is slightly less than half ot measured
plasma cocaine levels. This difference in plasma drug levels may be due in part to
differences in anesthesia which the rats in this experiment were exposed to compared to the
one on which we based our calculations (Nobiletti et al., 1994).
The acute tolerance studies consisted of an initial bolus of cocaine, cocaethylene, or
isopropyl cocaine followed immediately by a three hour infusion phase; all rats received a
cocaine challenge at the end of the infusion. Microdialysis results from the group receiving
a constant infusion of cocaine from times 0 to 180 minutes after bolus injection are
presented in Figure 3. Results from the group receiving a constant infusion of cocaethylene
is shown by Figure 4, and those for the isopropyl cocaine group are seen in Figure 5. Table 4:
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Absolute Microdialysis Basal Levels presents basal dopamine values for the three groups which
did not differ significantly.
Large

increases in dopamine levels

were seen with an initial

bolus of drug

(3 /jmol/kg) in the animals receiving cocaine and cocaethylene but not with isopropyl
cocaine. Using repeated measures ANOVA, there was a statistically significant increase in
dopamine concentration in the nucleus accumbens starting Irom 40 minutes prior until 20
minutes loilowing bolus 1 administration of cocaine (F = 11.174, p = 0.0006); dopamine
levels reached 163.5 ± 19.0% of baseline levels. Comparing over time starting from the
same 40 minutes of baseline samples immediately prior to drug bolus until 20 minute
after cocaethylene administration, statistical significance was seen {F = 4.823, p = 0.021)
with a mean dopamine level of 171.7 ± 25.17%. However, administration of isopropyl
cocaine resulted in no significant increase in nucleus accumbens dopamine levels {F =0.088,
p= 0.9168).

Table 4: Absolute Microdialysis Basal Levels
dray

mean ± S.E.M. ifmo/JuL)

n

cocaine

0.54 ±0.06

11

cocaethylene

0.65 ± 0.06

10

isopropyl cocaine

0.36 ± 0.05

6

Mean values measured in femtomoles per microliter (fmol//iL)
Basal values were not significantly different between groups (p> 0.14)
In

order

to

determine

the

impact

of

the

cocaine

challenge

following the

bolus/infusion pretreatment, repeated measures ANOVA of the data—corresponding to 40
minutes before cocaine challenge until 20 minutes after the challenge—was performed.
There was no significant effect in the group receiving a constant infusion of cocaine
{F= 2.191, p = 0.1379) or in the cocaethylene group (F= 2.444, p = 0.1151), but the change
was statistically significant in the isopropyl cocaine group (F = 8.349, p = 0.0185) yielding
a mean value of 168 ± 17.7% of the immediately

preceding baseline (one hour before

challenge) (Please refer to Figure 6). The baseline immediately

preceding challenge was

used rather than the one from times -60 to 0 minutes because of differences in steady-state
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dopamine levels between the two; the interest was in the change to a cocaine challenge from
the immediate pre-challenge state. Cocaine animals had a stable, elevated dopamine level
during the three hour drug exposure; cocaethylene animals had a decreasing and then
increasing level. Though the trend was an increase in dopamine levels in all three groups
after cocaine challenge, the only significant increase was seen with the isopropyl cocaine
group. A statistically significantly response to the challenge is expected in animals that do
not have tolerance to cocaine, as seen in drug naive animals and rats pretreated with
isopropyl cocaine.
The effects of the pretreatment study drugs (cocaine, cocaethylene, and isopropyl
cocaine) on the dopamine levels over time is different in each case. As seen in Figure 7, a
bolus and constant infusion of cocaine causes a stable elevation of dopamine concentration
throughout the maintenance phase of the experiment. Cocaethylene causes an immediate
peak in dopamine levels after the loading dose is given, but then drops to baseline levels
by two hours of constant infusion at which time the dopamine levels begin to rise again.
Isopropyl cocaine at this low concentration, much like an inactive control, has virtually no
effect on dopamine levels during the course of the experiment.
For behavioral data,

Figures 8-10 are labeled

Cocaine Behavior,

Cocaethylene

Behavior, and Isopropyl Cocaine Behavior in a fashion analogous to that used in the
microdialysis charts. The y-axis denotes the mean number of non-consecutive beam breaks
made in a five minute period as described in section 2.4, Behavioral Studies for Acute
Folerance Studies. Standard error bars are included. A combined graph of all three data
sets combined without error bars follows in Figure 11.
Statistically significant increases in activity were seen following the initial bolus of
drug in the cocaine and cocaethylene groups but not in the isopropyl

cocaine group.

Increased activity from a mean of 1.1 ±0.1 counts per five minute time bin 60 minutes
prior to bolus 1 to 7.5 ± 0.8 non-consecutive beam breaks per time bin in the 20 minutes
following the first pre-infusion bolus (0 minutes post-injection) was statistically significant
(F= 11.005, p = 0.0001) in the cocaine group using repeated measures ANOVA. For the
group receiving cocaethylene as bolus 1, the change in behavior from a baseline of 2.3 ± 0.3
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to a value of 6.2 ± 1.1 counts per five minutes was also significant {F = 2.587, p = 0.0012).
There was no significant increase in activity in the isopropyl cocaine groups over the same
time period (F = 0.899, p = 0.5672).
By repeated measures ANOVA all study animals demonstrated significant increases
in activity to cocaine challenge after a three hour maintenance phase on their respective drug
(see Figure 12). The activity in the cocaine group increased to a maximum of 19.4 ± 3-5
counts per five minutes following cocaine challenge compared to the preceding 60 minute
mean of 11.5 ± 0.9 counts per five minutes; the trend over this period of time was
statistically significant by repeated measures ANOVA (F = 5.402, p = 0.0001). Increased
activity with cocaine challenge at the same time intervals was also statistically significant
in both the cocaethylene group from 2.8 ± 0.4 to 8.4 ± 1.7 counts per five minutes (F =
2.259, p= 0.0101) and in the isopropyl cocaine group from 0.7 ± 0.2 to 6.0 ± 1.2 counts
per five minutes (F = 2.218, p = 0.0155).
With two way repeated measures ANOVA, there were no significant differences in
activity when comparing between groups from 15 minutes before the cocaine challenge
(165 minutes post-injection of bolus 1) to 15 minutes after cocaine challenge. However,
when comparing the maximal locomotor response of rats in five minute time periods after
cocaine challenge using an unpaired, two-tailed t-test, there was a statistically significant
difference between cocaine and cocaethylene groups {p = 0.0095) and between cocaine and
isopropyl cocaine groups (p = 0.0372), but not between cocaethylene and isopropyl cocaine
groups (p = 0.5024). The absolute activity of each groups is shown in Figure 12. Figure 13
shows the amount of locomotor change seen in each group after a cocaine challenge.

32 Results from Isopropyl Cocaine Dosing Studies
The purpose of these experiments was to determine the dose of isopropyl cocaine
that would elicit an equivalent dopamine response in the nucleus accumbens as seen with
3 //mol/kg cocaine in the anesthetized rat. This has never been studied previously.
One group of rats received cocaine at 3 //mol/kg, another group received isopropyl
cocaine at 6 pmol/kg, and a third was treated with isopropyl cocaine at 12 /zmol/kg. The
results from these three groups are shown in Figure 14. The dopamine increases in the
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nucleus accumbens when compared to baseline values were statistically significant in the
3 ^mol/kg cocaine group {F = 17.916, p = 0.0133); the mean change in this group was
441.68 ± 93.55%. Dopamine levels alter a bolus ol isopropyl cocaine at 6 /imol/kg
peaked at 185.10 ± 27.66%; however, this was not statistically significant (F = 3.992,
p=9.\\GA).

A

bolus of 12

/imol/kg

resulted

in

a

mean

dopamine

response

ol

236.06 ± 13.55% which was significant (F = 28.344, p = 0.006). In another group of three
animals given a bolus ol 24 pinol/kg isopropyl cocaine, two died immediately. Thus this
dosage was abandoned, and the only surviving rat showed a nucleus accumbens dopamine
response of 362.07% baseline after injection. A challenge ol both 3 /nnol/kg cocaine and
12 /^mol/kg isopropyl cocaine together resulted in a response of 497.98 ± 39.51% ol
baseline in two rats. Thus it did not appear that the concurrent presence of isopropyl
cocaine diminished the effect of cocaine.

33 Results from Chronic Tolerance Studies
Figures 15-22 in this section depict the behavior ol rats that have undergone a seven
day continuous infusion of control (water), cocaine, cocaethylene, or isopropyl cocaine.
Figures 15-18 document activity of the animals on the night before the experiments, and
Figures 19—22 show the experimental session which included the cocaine challenge: the
continuous infusion was stopped

120 minutes belore

the cocaine challenge to allow

sufficient time for clearance of drug, and a bolus of cocaine was given at time zero.
There was a slight basal activation at night from cocaine and cocaethylene in the
chronically treated animals that was not observed in the isopropyl cocaine or control
groups. When using two way repeated measures ANOVA to analyze activity between groups
at night beginning approximately one hour prior to darkness, there was no statistically
significant

difference

between

cocaine

and

isopropyl

cocaine

animals,

cocaine

and

cocaethylene rats, cocaethylene and isopropyl cocaine subjects, or isopropyl cocaine versus
control animals. There was a significant difference between cocaine and control animals at
night (F = 1.622, p = 0.0012) and between cocaethylene and control groups (F = 1.313,
p - 0.0472). On Figure 23, the differences in night activity between the groups are shown.
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There was tolerance to subsequent cocaine challenge following chronic cocaine and
cocaethylene treatments which was not seen with rats maintained chronically on isopropyl
cocaine or water. A bar graph comparing the total activity per rat in the 5-20 minutes after
cocaine challenge for cocaine-, cocaethylene-, and water-maintained animals is found in
Figure 24. This period corresponds to the time of drug action. One way repeated measures
analysis of variance of the data from 30 minutes pre- to 30 minutes post-challenge showed
a significant increase in activity in the control group {F = 3.464, p = 0.0003). There was no
significant increase in behavior following challenge in the group receiving seven days of
continuous cocaine infusion (F = 0.735, p = 0.7129). The cocaethylene group also showed no
statistically significant increase in activity

(F = 0.769, p = 0.6792). In contrast to the

cocaine and cocaethylene groups, the increase in activity was statistically significant in the
isopropyl cocaine group {F = 3.023, p = 0.0023). Multifactorial ANOVA examining the
total activity from 5-20 minutes per rat (see Figure 24) shows significant differences
between the cocaine and control groups as well as between the cocaethylene and control
groups.

4. DISCUSSION
4.1 Discussion Introduction
The prevalence of cocaine abuse and its impact on society has necessitated the
search for an effective therapy to cocaine addiction, a disease for which there are currently
no good treatments. As methadone is able to blunt the effects of subsequent heroin use by
inducing tolerance, an analogous compound aimed at producing cross-tolerance to cocaine
may be useful in treating cocaine addiction. The search for a pharmacological treatment of
cocaine addiction is the basis of this present study.
These experiments examined the impact of acute and chronic treatment with
cocaine, cocaethylene, and isopropyl cocaine on dopamine levels in the nucleus accumbens
(Acute Tolerance Studies only) and also

on locomotor

behavior in the rat, and in

particular, compared the effects of a subsequent cocaine challenge. It was hypothesized that
continuous infusion of cocaine, cocaethylene, or isopropyl cocaine would blunt response to a
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later bolus of cocaine; if this hypothesis were proved correct, then some or all of these
compounds could potentially lead the way to a pharmacological management of cocaine
addiction. As mentioned in section 1, Introduction, various studies have demonstrated
tolerance with continuous cocaine administration (Emmett-Oglesby et al., 1993; Frank et
al., 1992; Katz et al., 1992; Masserano et al., 1994). It appears Irom our results that we have
demonstrated

tolerance

to

some

of

the

dosing

regimens

utilizing

intravenous

administration of drug as discussed below.
Chronic treatment with cocaine and cocaethylene produced behavioral tolerance.
Acute (three hours) maintenance of cocaine and cocaethylene produced a suggestion of
neurochemical tolerance but no behavioral tolerance. Isopropyl

cocaine produced little

effect on the rats neurochemically or behaviorally though may be due to a dose used that
was too small.

42

Discussion for Acute Tolerance Studies
Cocaine and cocaethylene are approximately equal in their ability

to elevate

extracellular dopamine levels with an acute bolus infusion as seen in Figure 7. The mean
increase in dopamine levels in response to the initial cocaethylene bolus was similar to that
elicited trom the cocaine in the Acute Tolerance studies which is consistent with an earlier
study using anesthetized rats. (Bradberry et al., 1993). The initial isopropyl cocaine bolus
resulted in no change in extracellular dopamine concentrations. Though isopropyl cocaine
is approximately 50 times more selective for dopamine than lor serotonin transporters, it
is known to be 15-25 times less active at both sites (Elsworth et al., 1993; Jatlow and
Bradberry personal communication). Thus the lack of dopamine effect from isopropyl
cocaine administration may be a dose effect.
These microdialysis

data are consistent with what is known about these three

compounds as it relates to the rat. Cocaine and cocaethylene both elicit large extracellular
dopamine responses; both were approximately equipotent in ability to increase dopamine
levels from baseline. Isopropyl cocaine is clearly the least active of the three compounds in
terms of extracellular dopamine response.
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The time course of altered dopamine resulting from the three drugs appears to
differ during the maintenance phase of the study. Cocaine causes a dopamine increase which
is maintained at a stable level throughout the constant infusion. Cocaethylene causes a peak
in the extracellular dopamine concentration 20 minutes after the loading dose, but this
level drops constantly for 100 minutes. This may suggest that cocaethylene demonstrates
tolerance to itself over time with respect to dopamine elevation. After 100 minutes, the
extracellular dopamine concentration rises until the cocaine challenge. The exact cause for
this increase in dopamine concentration after 100 minutes is currently unclear. Extracellular
dopamine

levels

after

isopropyl

cocaine administration

remains at

throughout the constant infusion which is expected since the initial

baseline

levels

bolus of isopropyl

cocaine at 3 //mol/kg resulted in no effect on dopamine.
No conclusions can be drawn regarding the effects of an acute maintenance of drug
on neurochemical tolerance to subsequent cocaine because of the difficulties in interpreting
the steady-state dopamine levels: dopamine levels are high throughout the experiment in
the cocaine group, and dopamine levels are steadily increasing in the cocaethylene group—
even before the cocaine challenge. Extracellular dopamine levels increased after the cocaine
challenge in all

groups. Using one way repeated

measures ANOVA, the cocaine and

cocaethylene groups showed no statistical change when comparing dopamine levels before
and after cocaine challenge. This may be a result of acute neurochemical tolerance since the
effect of the cocaine bolus resulted in minimal dopamine elevation, or in the case of
cocaine, it may be due to the fact that all cocaine receptors were saturated which would
imply that any additional cocaine administered (such as the challenge) would have no
effect on the animals.
When examining behavioral response to the initial

bolus of drug, there was a

statistically significant increase in behavior with cocaine and cocaethylene groups (see
Figure 11). This behavioral activation was not seen with isopropyl cocaine suggesting again
that this compound is less potent than cocaine and cocaethylene when examining nucleus
accumbens dopamine activation or locomotor activation at these dosages. Also seen is that
the

behavioral

and

neurochemical

effects

are

consistent—or

parallel—within

this

Yale University School of Medicine Thesis

Tobias T- Lee

Page 19

experimental paradigm: cocaine animals exhibited increasing behavioral activation during
the maintenance phase while during that same time dopamine was constantly elevated
above pretreatment levels; cocaethylene animals had falling dopamine levels during early
maintenance and showed locomotor activity

during that same

period

that tell

to

pretreatment levels.
The behavioral trends in cocaine, cocaethylene, and isopropyl cocaine groups were
similar after a cocaine challenge in the Acute Tolerance studies. The cocaine infusion
group showed greater absolute behavioral activation with a cocaine challenge than the other
two groups. While cocaine and cocaethylene bind the dopamine transporter equipotently,
their main difference is a relatively greater affinity of cocaine for the serotonin transporter
than

cocaethylene

and

isopropyl

cocaine.

This

may

result

in

serotonin-related

augmentation of behavior from cocaine as described in previous studies (Cameron and
Williams,

1994; Parsons et al., 1996). The differences in dopamine and serotonin

transporter selectivity could account for the increased behavioral activation seen in the
cocaine bolus/infusion group compared to animals receiving cocaethylene or isopropyl
cocaine bolus/infusion.
The analysis of data from the Acute Tolerance studies yielded

no definite

evidence for the development of tolerance in a three hour period. These data were difficult
to interpret because of the unstable locomotor activity levels immediately

prior to

challenge in the cocaine group. Even during the maintenance phase of the experiment, the
cocaine-treated rats showed continually increasing behavioral activation. This phenomenon
was not seen with the cocaethylene-treated rats; their activity returned to baseline during
the three hour infusion, and they responded no differently to a cocaine challenge than the
isopropyl cocaine rats (who were treated with such a small dose of isopropyl cocaine that
it was presumed to have been equivalent to placebo). Thus, acutely, it can be concluded
that cocaethylene causes less behavioral activation than cocaine.
43 Discussion for Isopropyl Cocaine Dosing Studies in the Anesthetized Rat
In order to compare the potency of isopropyl cocaine with cocaine, the experiments
on chloral hydrate anesthetized rats were conducted (see Figure 14). While a dose of

isopropyl cocaine at 6 /tmol/kg
increase
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that was

resulted

not statistically

in an extracellular

significant,

12 /miol/kg

dopamine
yielded

significant response. However, even at this dosage, the maximal

concentration
a

statistically

response was a mean ol

236.06 ±13.35% baseline for the group—much less than the 441.68 ± 93.55% of baseline
response elicited by a cocaine challenge. When the administered dose was doubled to 24
/tmol/kg, two of the three rats died immediately after injection. Thus, this line ol pursuit
was abandoned with the conclusion that the lethal dose of isopropyl cocaine was less than
the dose required to elicit a dopamine response similar to that lound alter cocaine infusion
in chloral hydrate anesthetized rats. Cocaethylene has also been previously described as
having a lower lethal dose than cocaine (Hearn et al., 1991). It is currently unclear why the
cocaine analogs appear to be more toxic than the parent compound.
Peak

response to

cocaine

was significantly

greater

lor

the

chloral

hydrate

anesthetized rats than for the awake animal. Our data show that a bolus ol 3 /imol/kg
cocaine via jugular catheter in a previously drug-naive animal increases dopamine levels in
the nucleus accumbens to a statistically significant degree Irom baseline. It is interesting to
note that the previous studies using chloral hydrate anesthetized rats at the same challenge
doses (though with only a bolus and no infusion) showed a statistically significant increase
in nucleus accumbens dopamine levels ranging from 304% to 400% of baseline while the
present study with awake animals responded with an increase to only 163.5 ± 19.0% of
baseline (Bradberry et al., 1993; Bradberry and Roth, 1989; Jatlow et al., 1991). The
difference in dopamine elevation when comparing awake and anesthetized rats receiving
the same doses of drug was also demonstrated in these studies and might be a consequence
of a drug interaction between cocaine and chloral hydrate though the exact mechanism is
currently unclear. The presence of chloral hydrate seems to augment the extracellular
dopamine response in the nucleus accumbens.

4.4 Discussion for Chronic Tolerance Studies
Doses for the seven day constant infusion studies were much less than that given in
the acute trials (Table 3: Minipump Study Drugs in Section 2.8: Chronic Tolerance Studies).
Estimated

plasma concentrations were between

85

and

90

ng/ml

for

cocaine and
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to be approximately

47

ng/ml for the isopropyl cocaine rats—the isopropyl cocaine animals were given a dose hall
that of animals in the other treatment groups due to limited availability of this specially
synthesized compound—though these target plasma concentrations may be underestimates
as described in section 3.1, Results from Acute Tolerance Studies. Plasma concentrations
were less hut sustained lor a greater amount of time when the seven day constant infusion
study is compared to the three hour study. There was no statistically significant increase in
activity

subsequent to cocaine challenge

in

the chronically

maintained

cocaine

and

cocaethylene groups. Thus it appears that behavioral tolerance was achieved in these two
groups. On the other hand, behavioral activation by a subsequent cocaine challenge was seen
with a statistically significant increase in activity for the animals that were subjected to the
control or to isopropyl cocaine for a week. This suggested that no behavioral tolerance was
achieved lor either of these groups at the maintenance levels provided.
While it is clear that there is little

difference in the behavior after challenge

between control and isopropyl cocaine groups using these dosages, it is unclear whether the
amount of isopropyl cocaine given was enough to produce a physiologically significant
alteration in response to a cocaine challenge. It is possible that the plasma levels of the
isopropyl cocaine during the week of infusion were too low to be able

to effect a

subsequendy change in behavior. Possibly a higher dose of isopropyl cocaine than we had
employed—but a less

than lethal

one—might produce tolerance. A

compound like

isopropyl cocaine that has more activity at the dopamine axis and relatively even less at
the serotonin one than cocaethylene may have better promise as a drug used to treat cocaine
addiction since theoretically it would still decrease the cocaine-induced euphoria but be
even less behaviorally activating than cocaethylene.

45 General Discussion
From these studies it appears that neurochemicai and behavioral
cocaine develops at different times

tolerance to

with respect to length of continuous cocaine or

cocaethylene infusion required. With cocaine and cocaethylene pretreatment, the ability of
a cocaine challenge to elevate extracellular dopamine levels was reduced within three hours
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of constant infusion (though it is not clear whether true tolerance was achieved as described
in section 4.2, Discussion for Acute Tolerance Studies). By giving rats a constant infusion of
drug—cocaine

or cocaethylene—lor

seven days,

behavioral

tolerance

Throughout these experiments, isopropyl cocaine at the dosages used did

was

observed.

not display an

ability to produce cross-tolerance to subsequent cocaine administration neurochemically or
behaviorally though this may be a result of the low potency ol this compound (as measured
by extracellular dopamine concentrations and locomotion) compared to the other two and
the relatively low doses used. In fact, isopropyl cocaine-treated rats displayed

the same

behavior in the seven day continuous infusion experiments as the control group.
The schedule of drug administration as well as the dosage play a significant role in
the effect of a subsequent cocaine challenge. When rats were given the pretreatment of
120 jUmol/kg cocaine daily by osmotic minipump and subject to the same trials after one
or seven days of withdrawal, tolerance was observed (King et ai, 1992). A pretreatment
schedule of cocaine given at 60 /rmol/kg three times a day was found to produce tolerance
by day two which remained at 60% of baseline from days four through 10 (EmmettOglesby et ai, 1993). Acute tolerance to cocaine has also been reported to occur in humans
(Foltin and Fischman, 1991; Foltin et al., 1990). While tolerance has been observed in
animal

trials,

the exact

parameters

of drug administration

to

achieve

either state

successfully are still under study. In general, it is believed that a constant infusion of a pre¬
challenge drug, in this case cocaine or cocaethylene, causes tolerance.
While previous experiments have confined themselves to higher doses of the study
medications, possibly because drug administration was not intravenous and dius resulted in
lower bioavailability of drug, this present study used 3 /zmol/kg for the first bolus—the
loading dose—followed by 3 /imol/hour for three hours in the acute studies. The seven day
continuous drug infusion and behavior studies used 32.6 /rmol/day for the cocaine and
cocaethylene studies; the pretreatment was 16.3 ^mol/day for isopropyl cocaine. Drug
doses for present chronic administration studies were only slightly

less

than used in

previously reported trials. Even with these lower doses, tolerance was still observed using
these dosing schedules.
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Infusion rates in the present experiments were based on drug clearance which is
equal to the product of the target steady state drug concentration and the total
clearance of compound. Clearance rates for intravenously administered

body

cocaine

and

cocaethylene have been previously described as 73.5 ± 9.5 ml/min and 82.8 ± 7.4 ml/min
respectively

(Nobiletti

et al., 1994). Isopropyl

cocaine clearance

rates are currently

unknown and could only be presumed at present.
Human states of euphoria derived from these drugs clearly cannot necessarily be
equated with the behavioral activation seen in rats. At present, behavioral measurements
such as the amount of grooming, locomotor activity, or other stereotypical movements are
a popular method for determining the level of response achieved by drug administration.
Microdialysis is a method to quantify the neurochemical drug response. However, it is
uncertain

how well

these

measurements

might

correlate

with

euphoric states.

The

importance of examining dopamine concentrations at the nucleus accumbens is suggested
by studies showing that dopaminergic projections to the nucleus accumbens are required for
the development

of

cocaine

self-administration

(Roberts

and

Koob,

administration animal paradigms may better reflect the ability

1982).

Self-

a certain drug has in

causing euphoria in people and may be the next step in future studies. And of course, this is
one of the goals of current drug studies. We want to understand how compounds such as
cocaine cause euphoria and tolerance because we wish to discover methods by which we can
modulate these responses in humans. In this way, we may be able to find better modalities
to treat cocaine abuse. Rat drug self-administration has been utilized with some success.
One study suggested that rats titrate the amount of cocaine during self-administration to
maintain a fairly constant, elevated dopamine level in the nucleus accumbens (Pettit and
Justice, 1989); this leads

us to believe that the reinforcing properties of cocaine are

specifically related to extracellular dopamine levels in the nucleus accumbens. Another
study

using

self-administration

was

shown

to

demonstrate

no

difference

in

the

development of tolerance compared to continuous or intermittent drug administration
schedules (Emmett-Oglesby

et al., 1993). The Emmett-Oglesby

et al. study simply

explored another schedule of drug administration and its relationship to the development

*
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of tolerance; it did not elucidate the relationship between the state of drug tolerance, once
achieved, and the subsequent effects it had on behavior. It may he interesting to ask the
question: how different are the rates of self-administration when comparing a group of rats
that has developed neurochemical or behavioral tolerance to a control group. Then we
begin to examine the concept of tolerance as it relates to craving and possibly to euphoria.

4j6 Conclusion
In summary, the Chronic Tolerance studies showed that behavioral tolerance was
seen in rats pretreated with cocaine or cocaethylene when challenged with cocaine; die
behavior of the isopropyl cocaine group appeared to be no different than that of the control.
Rats pretreated with three hours of cocaine or cocaethylene in the Acute Tolerance studies
showed a decreased change in dopamine levels due to a cocaine challenge compared to
isopropyl

cocaine animals; because these data are difficult

to

interpret it

cannot be

definitively stated that tolerance was observed though tolerance is certainly suggested.
There was no behavioral tolerance seen to a cocaine challenge during the Acute Tolerance
study. However, during the Acute Tolerance study, it was observed that cocaethylene
maintained animals displayed activation that was not sustained (both neurochemically and
behaviorally) suggesting that cocaethylene may produce acute tolerance to itself. In the
Isopropyl Cocaine Dosing Studies in the anesthetized rat, the extracellular dopamine
response seen was found to be about four times that seen in awake rats when given a cocaine
challenge.

Isopropyl

cocaine

was

much

less

potent

than

cocaine

on

eliciting

a

neurochemical change: the amount of isopropyl cocaine required to increase dopamine
concentrations in the nucleus accumbens the same amount as seen when an anesthetized rat
was given a challenge of 3 /rmol/kg cocaine appears to be greater than the lethal dose. The
dopamine response to isopropyl cocaine at 12 /rmol/kg was still only 236 ± 13.33% of
baseline in contrast to the 441.68 ± 93.55% of the baseline value seen with 3 /rmol/kg
cocaine.
Behavioral tolerance to cocaine can be achieved with a chronic cocaethylene pre¬
treatment. The characteristics of cocaethylene show some promise as a model for possible
pharmacological therapies for cocaine addiction: as known previously, cocaethylene is
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more selective lor dopamine than serotonin when compared to cocaine; this cocaine analog
is cleared more slowly and has a longer half-life than cocaine; and as seen with the Acute
Tolerance studies, it is less activating than cocaine acutely. An examination of cocaine and
the two cocaine analogs at different doses or drug administration schedules may bring out
more ol the unique qualities
utilizing a self-administration
important questions.

that each compound possesses.
paradigm,

Further studies,

perhaps

may answer some of these interesting and
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5. FIGURES AND GRAPHS
Figure 1: Cocaine, Cocaethylene and Isopropyl Cocaine Structures
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Figure 2: Microdialysis Probe
(not drawn to scale)
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Figure 3: Mean values (± SEM) of extracellular

dopamine

response to IV boluses of

cocaine (3 /rmol/kg) at times 0 and 180 with an intervening constant infusion of cocaine
(51 nmoL/min) from times 0-180 minutes (n = 11).
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(n=10)
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Figure

4: Mean values (± SEM) of extracellular

cocaethylene (3 /imol/kg) at time 0 followed
(51 nmol/min)

until

time

180

minutes

by

dopamine

response to IV bolus ot

a constant infusion

and challenged

with

a

of cocaethylene

bolus

of

cocaine

(3 /tmol/kg) at time 180 minutes (n - 10).
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Figure

5: Mean values (± SEM) of extracellular

isopropyl cocaine (3 /imol/kg) at time 0 followed

dopamine response to IV bolus of
by

a constant infusion of isopropyl

cocaine (51 nmol/min) until time 180 minutes and challenged with a bolus of cocaine
(3 //mol/kg) at time 180 minutes (n = 6).
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250 -i

Percentage increase from pre-challenge baseline

Dopamine Levels

r 250

in Nucleus Accumbens
Following cocaine
challenge (t = 0)
200

-

-200

- 150

Levels (Percentage

ot

Pre-challenge

Baseline)

Dopamine Levels in Nucleus Accumbens

-

100

Dopamine

-50

0

Pretreatment

Group

Figure 6: Mean (± SEM) extracellular
cocaine
baseline

(3 /imol/kg) at time
(times

140 to 180)

Drug Naive Rat

dopamine concentrations after IV challenge of

200 minutes as a percentage of immediately
lor

rats pretreated with

a 3 hour infusion

preceding
of cocaine,

cocaethylene, and isopropyl cocaine. Far right graph shows mean (± SEM) extracellular
dopamine concentrations alter IV challenge of cocaine (3 ^mol/kg) at time 0 (drug naive
rat) as a percentage of immediately

preceding

baseline.

Cocaine-

and cocaethylene-

maintained rats show similar response trends while isopropyl cocaine- and drug-naive-rats
exhibit similar responses to a cocaine challenge.
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Microdialysis Graphs Combined
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Figure 7: Mean values (± SEM) of extracellular
of cocaine, cocaethylene, or isopropyl

—I—

120

cocaine

dopamine response to IV bolus/infusion
(3 /imol/kg

bolus

and

51 nmol/min

infusion) at time 0 until time 180 minutes and challenged with cocaine (3 /rmoL/kg) at
time 180 minutes.

240
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Cocaine

Behavior (n = 32)

Figure 8: Mean values (± SEM) ol non-consecutive beam breaks measuring

locomotor

activity subsequent to IV bolus of cocaine (3 /Jmol/kg) at time 0 and time 180 minutes with
a constant cocaine infusion (51 nmol/min) from time 0 to time 180 minutes (n = 32).

Cocaethylene

Behavior (n=20)

Figure 9: Mean values (± SEM) of non-consecutive beam breaks measuring

locomotor

activity subsequent to IV bolus of cocaethylene (3 /imol/kg) at time 0 minutes followed by
infusion

of cocaethylene (51 nmol/min)

until

cocaine (3 /tmol/kg) at time 180 minutes {n = 20).

time

180 minutes and challenged

with

Tobtas T Lee
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Behavior (n = 10)

Figure 10: Mean values (± SEM) of non-consecutive beam breaks measuring locomotor
activity subsequent to IV bolus of isopropyl

cocaine (3 /imol/kg) at time

followed by infusion of isopropyl cocaine (51 nmol/min)

until

challenged with cocaine (3 /imol/kg) at time 180 minutes (« = 10).

time

0 minutes

180 minutes and
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Behavior Graphs Combined

Mean

Counts

Standard error bars omitted for clarity

Figure

11: Mean values of non-consecutive beam breaks measuring locomotor activity

subsequent to an IV bolus/infusion

of cocaine, cocaethylene, or isopropyl

cocaine

(3

/imol/kg bolus and 51 nmol/min infusion) until time 180 minutes and challenged with
cocaine (3/imol/kg) at time 180 minutes. SEM bars were omitted for clarity.
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Maximal Locomotor Activity
after Cocaine Challenge
25

n

r 25

Maximal Behavioral
Response Following Cocaine
Challenge (t = 0)

Activity

20 H

Locomotor

-15

Cocaine (n=32)

Cocaethylene (n=20)
Pretreatment

Figure

Isopropyl Cocaine (n=10)

Drug Naive Rat

Group

12: Left three graphs show mean (± SEM)

Cocaine (n=32; t=0)

locomotor

activity as measured by

nonconsecutive infrared beam breaks during a five minute period of greatest activity after
IV challenge of cocaine (3 /xmol/kg) at time 180 minute for rats pretreated with cocaine,
cocaethylene, and isopropyl cocaine. Far right graph shows mean maximal

locomotor

activity (± SEM) during a five minute period immediately after IV challenge of cocaine
(3 /rmol/kg) at time 0 (drug naive rats) preceding maintenance in the cocaine group.
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Group

Figure 13: Mean change in locomotor activity from immediately preceding baseline (15
minute period prior to challenge) as measured by nonconsecutive infrared

beam breaks

during a five minute period during the period of greatest activity after FV challenge of
cocaine (3 /imol/kg) at time 180 minute for rats pretreated with cocaine, cocaethylene, and
isopropyl cocaine. Error bars omitted.
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Microdialysis for Anesthetized Rat Dosing Studies
600 550 -

450 -

(Percent

400 350 -
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-120

-60

Time post-injection

Figure

0

(min)

60

t

14: Mean values (± SEM) of extracellular

dopamine response to cocaine at 3

/imol/kg {n = 5) compared to isopropyl cocaine at 6 /imol/kg (n = 5) and 12 /imol/kg (n = 5)
doses in anesthetized rats.

120
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Mini-pump Behavior Night Control (n=9)
30 n

25 -

Figure 15: Mean values (± SEM) of non-consecutive beam breaks in five minute time bins
measuring rat locomotor activity starting approximately one hour before darkness on day
six of a seven day control (water) infusion by mini-pump {n = 9).

Mini-Pump Behavior Night Cocaine (n=7)

Figure 16: Mean values (± SEM) of non-consecutive beam breaks in five minute time bins
measuring rat locomotor activity starting approximately one hour before darkness on day
six of a seven day cocaine (7.7 /tg/min; 22.6 nmol/min) infusion by mini-pump (« = 7).
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Mini-pump Behavior Night Cocaethylene (n=6)

Figure 17: Mean values (± SEM) of non-consecutive beam breaks in five minute time bins
measuring rat locomotor activity starting approximately one hour before darkness on day
six of a seven day cocaethylene (11.1 /rg/min; 22.6 nmol/min) mini-pump infusion {n - 6).

Mini-pump Behavior Night Isopropyl Cocaine (n=6)

Figure 18: Mean values (± SEM) of non-consecutive beam breaks in five minute time bins
measuring rat locomotor activity starting approximately one hour before darkness on day
six of a seven day isopropyl cocaine (4.6 /ig/min; 11.3 nmol/min) infusion by mini-pump
(«=

6).
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Mini-pump Behavior Control (n=9)
30

-i

25

-

Figure 19: Mean values (± SEM) of non-consecutive beam breaks in five minute time bins
measuring rat locomotor activity when a seven day infusion of control (water) was stopped
at -120 minutes and a bolus of cocaine (3 ^rmol/kg) was given at time 0 minutes (n = 9).

Mini-pump

Behavior Cocaine (n=7)

Figure 20: Mean values (± SEM) of non-consecutive beam breaks in five minute time bins
measuring rat locomotor activity when a seven day infusion of cocaine (7.7 ^ig/min; 22.6
nmol/min) was stopped at -120 minutes and a bolus of cocaine (3 /imol/kg) was given at
time 0 minutes (n - 7).
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Mini-pump Behavior Cocaethylene (n=5)

Figure 21: Mean values (± SEM) of non-consecutive beam breaks in five minute time bins
measuring rat locomotor activity when a seven day infusion of cocaethylene (11.1 /ig/min;
22.6 nmol/min) was stopped at -120 minutes and a bolus of cocaine (3 /imol/kg) was given
at time 0 minutes (« = 5)-

Mini-pump Behavior Isopropyl Cocaine (n=6)

Figure 22: Mean values (± SEM) of non-consecutive beam breaks in five minute time bins
measuring

rat

locomotor

activity

(4.6/rg/min; 11.3 nmol/min)

after

seven

day

was stopped at -120

(3 /imol/kg) was given at time 0 minutes (n = 6).

infusion
minutes

of

isopropyl

and a bolus

cocaine

of cocaine
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Mean Total Beam Breaks Over Six Hours Per Rat

Tobias T. Lee

Pretreatment

Group

Figure 23: Mean total number of non-consecutive beam breaks (± SEM) over six hours of
rats in various pretreatment groups (cocaine, cocaethylene, isopropyl cocaine, and control)
one day prior to testing. Measurements started approximately one hour before darkness.
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Locomotor Activity in Chronically Treated Rats
30-i

Average 15 minute response per rat immediately alter cocaine challenge
r 30
Baseline Activity

Total Counts Over 15 Minutes per Rat

(Pre-Challenge)
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-20

15-
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- 15
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-

5-

10

-5

0

0
Cocaine (n=7)

Cocaethylene (n=5)
Pretreatment

Water Control (n=9)

Group

Figure 24: Total number of non-consecutive beam breaks (± SEM) from
immediately following

Baseline (n=21)

5—20 minutes

cocaine challenge (time 0). Rats are from various pretreatment

groups (cocaine, cocaethylene, control, and baseline).
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